COMMUNIQUÉS West-GlobeNewswire

NovalGen to Begin World’s First Clinical Trial for a Self-Regulating Immunotherapy
17/09/2025
LONDON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- The world’s first therapeutic drug to be equipped with NovalGen’s pioneering AutoRegulation (AR) technology has been approved for evaluation in the clinic by the UK’s Medicine [...]
ADARx Pharmaceuticals Appoints Industry Veteran, Laura Shawver, Ph.D., as Board Chair
17/09/2025
– Accomplished biopharma executive and entrepreneur brings a 25-year track record of upscaling valuable companies and realizing the potential of their innovations – SAN DIEGO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- ADARx [...]
Palisade Bio Reports Positive PALI-2108 Phase 1b Clinical Data
17/09/2025
PALI-2108 demonstrated favorable safety, with no serious adverse events, lab abnormalities, or EKG concerns Phase 1b data demonstrated 100% clinical response and promising signals regarding the efficacy of PALI-2108 in [...]
XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc.
17/09/2025
HilleVax Stockholders Received $1.95 Per Share in Cash Plus a Contingent Value Right EMERYVILLE, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty” or the “Company”), a [...]
Nylon flexTAP®: First FDA cleared 3D-Printed Midline Oral Appliance for Sleep Apnea
17/09/2025
DALLAS, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Airway Management proudly announces a historic milestone with the FDA clearance of Nylon flexTAP ® , the world’s first digitally printed single-point midline oral appliance [...]
Synergy CHC Corp. (NASDAQ: SNYR) Partners with AlaBev to Launch FOCUSfactor® Beverages in 5,000+ Retail Outlets Across Alabama
17/09/2025
WESTBROOK, Maine, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) , a leading consumer health and wellness company, today announced a strategic distribution partnership with AlaBev , one of the [...]
24/7 Market News: Kraig Labs Spider Silk is Sustainable Alternative to Petroleum-Derived Plastics
17/09/2025
Nylon and Polyester Are Polluting the Planet with Microplastics DENVER, Sept. 17, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com , a pioneer in digital media dedicated to the swift distribution of financial market news and [...]
New Study Highlights the Potential of Hyperbaric Oxygen Therapy as a Biologically Based Treatment for Long-Term PTSD Symptom Improvement
17/09/2025
The study examined the long-term relief of PTSD symptoms in male veterans, highlighting the significant impact HBOT can have on alleviating the debilitating daily challenges they face ORLANDO, Fla., Sept. 17, 2025 ( [...]
Results from Phase 2 COURAGE Trial Demonstrating Potential to Improve Quality of GLP-1 receptor agonist-induced Weight Loss by Preserving Lean Mass, Presented at EASD
17/09/2025
Complete 26-week results further demonstrate that combining semaglutide with trevogrumab (anti-GDF8/anti-myostatin) helped prevent about half of semaglutide-induced loss of lean mass, while increasing fat mass loss [...]
Acentra Health Named one of the ‘Fastest Growing Companies’ by the Washington Business Journal
17/09/2025
Recognition highlights Acentra Health’s role as a vital healthcare partner to its growing roster of clients MCLEAN, Va., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Acentra Health , a technology and health solutions and services [...]
Notice of Annual General Meeting 2025
17/09/2025
ANNOUNCEMENT NO. 293 17 September 2025 Notice of Annual General Meeting Notice is hereby given of the Annual General Meeting, which will be held on Thursday 9 October 2025 at 5.30 p.m. The general meeting will be held [...]
Mapi Pharma Announces First Patient Recruited in Phase-I/II Study of Cariprazine Depot Once Monthly Injection
17/09/2025
NESS ZIONA, Israel, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on developing innovative long-acting depot injectable [...]
Foundation for Sarcoidosis Research Reacts to the Announcement of aTyr Pharma’s Phase 3 Clinical Trial Results
17/09/2025
CHICAGO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) expresses both solidarity and resolve as aTyr Pharma announced that its Phase 3 trial of efzofitimod in pulmonary sarcoidosis did [...]
MyCardiologist Launches Immediate Care Clinic, Offering Same-Day Access to Expert Cardiac Care
17/09/2025
MyCardiologistNow provides a new walk-in clinic for patients needing prompt evaluation of non-life-threatening heart symptoms MIAMI, Sept. 17, 2025 (GLOBE NEWSWIRE) -- MyCardiologist , one of South Florida’s leading [...]
Celldex Presents Data Demonstrating Barzolvolimab Improves Chronic Spontaneous Urticaria Independent of Baseline Immunoglobulin E levels in Phase 2 Study at EADV Congress 2025
17/09/2025
Rapid and sustained efficacy regardless of baseline IgE levels in patients with CSU HAMPTON, N.J., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today new data demonstrating rapid and strong [...]
Amphista Therapeutics discloses first details of its SMARCA2 degrader program
17/09/2025
Structurally-guided discovery using high-resolution cryo-EM has delivered potent, DCAF16-dependent Targeted Glues™ of SMARCA2, with exquisite selectivity over close homolog, SMARCA4. Rapid, deep and sustained [...]
AccuStem Sciences and EmeritusDX Expand Blood-Based Testing Capabilities to Advance Cancer Diagnostics and Treatment Planning
17/09/2025
PHOENIX, Ariz. and LONDON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT ), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, today [...]
Pneumagen Launches NeumoBind™ Technology Platform to Unlock New Opportunities in Intranasal Therapeutics
17/09/2025
Unique technology developed to extend residence time of therapeutic proteins on nasal and other mucosal surfaces Anchoring proteins in place can support enhanced activity Potential to utilise lower dose and reduced [...]
TRUE-See Announces Strategic Partnership with Dr. Peter Chang and the Center for Applied AI Research at the University of California, Irvine
17/09/2025
TRUE-See Expands Its AI Clinical Leadership Capabilities with Addition of Dr. Peter Chang as Senior AI Advisor NEW ORLEANS, Sept. 17, 2025 (GLOBE NEWSWIRE) -- TRUE-See, the leader in AI-driven, color-calibrated medical [...]

Pages